Report cover image

Global Oncology NGS Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750328

Description

Global Oncology NGS Databank Market Report


The Oncology NGS market was valued at $376.2 Million in 2022, and is projected to reach $1,143.6 Million by 2031 growing at a CAGR of 13.22% from 2023 to 2031. Targeted Sequencing & Resequencing segment is expected to be the highest contributor to this market, with $242.5 Million in 2022, and is anticipated to reach $709.3 Million by 2031, registering a CAGR of 12.73%. Whole Genome Sequencing segment is anticipated to reach $75.1 Million by 2031 with the highest CAGR of 14.43%. Targeted Sequencing & Resequencing and Whole Exome Sequencing segments collectively expected to account for about 94.0% share of the Oncology NGS market in 2022, with the former constituting around 64.5% share. Whole Genome Sequencing and Whole Exome Sequencing segments are expected to witness significant growth rates at a CAGR of 14.43% and 13.98% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 35.5% in the overall Oncology NGS market in 2022, and is anticipated to reach 38.0% by 2031.

Table of Contents

100 Pages
1. Global Oncology NGS Market, By Technology
1.1. Overview
1.2. Whole Genome Sequencing
1.2.1 Whole Genome Sequencing Market, By Region
1.2.1.1 North America Whole Genome Sequencing Market, By Country
1.2.1.2 Europe Whole Genome Sequencing Market, By Country
1.2.1.3 Asia-Pacific Whole Genome Sequencing Market, By Country
1.2.1.4 Rest of World Whole Genome Sequencing Market, By Country
1.3. Whole Exome Sequencing
1.3.1 Whole Exome Sequencing Market, By Region
1.3.1.1 North America Whole Exome Sequencing Market, By Country
1.3.1.2 Europe Whole Exome Sequencing Market, By Country
1.3.1.3 Asia-Pacific Whole Exome Sequencing Market, By Country
1.3.1.4 Rest of World Whole Exome Sequencing Market, By Country
1.4. Targeted Sequencing & Resequencing
1.4.1 Targeted Sequencing & Resequencing Market, By Region
1.4.1.1 North America Targeted Sequencing & Resequencing Market, By Country
1.4.1.2 Europe Targeted Sequencing & Resequencing Market, By Country
1.4.1.3 Asia-Pacific Targeted Sequencing & Resequencing Market, By Country
1.4.1.4 Rest of World Targeted Sequencing & Resequencing Market, By Country
2. Global Oncology NGS Market, By Workflow
2.1. Overview
2.2. NGS Pre-Sequencing
2.2.1 NGS Pre-Sequencing Market, By Region
2.2.1.1 North America NGS Pre-Sequencing Market, By Country
2.2.1.2 Europe NGS Pre-Sequencing Market, By Country
2.2.1.3 Asia-Pacific NGS Pre-Sequencing Market, By Country
2.2.1.4 Rest of World NGS Pre-Sequencing Market, By Country
2.3. NGS Sequencing
2.3.1 NGS Sequencing Market, By Region
2.3.1.1 North America NGS Sequencing Market, By Country
2.3.1.2 Europe NGS Sequencing Market, By Country
2.3.1.3 Asia-Pacific NGS Sequencing Market, By Country
2.3.1.4 Rest of World NGS Sequencing Market, By Country
2.4. NGS Data Analysis
2.4.1 NGS Data Analysis Market, By Region
2.4.1.1 North America NGS Data Analysis Market, By Country
2.4.1.2 Europe NGS Data Analysis Market, By Country
2.4.1.3 Asia-Pacific NGS Data Analysis Market, By Country
2.4.1.4 Rest of World NGS Data Analysis Market, By Country
3. Global Oncology NGS Market, By Application
3.1. Overview
3.2. Screening
3.2.1 Screening Market, By Region
3.2.1.1 North America Screening Market, By Country
3.2.1.2 Europe Screening Market, By Country
3.2.1.3 Asia-Pacific Screening Market, By Country
3.2.1.4 Rest of World Screening Market, By Country
3.3. Companion Diagnostics
3.3.1 Companion Diagnostics Market, By Region
3.3.1.1 North America Companion Diagnostics Market, By Country
3.3.1.2 Europe Companion Diagnostics Market, By Country
3.3.1.3 Asia-Pacific Companion Diagnostics Market, By Country
3.3.1.4 Rest of World Companion Diagnostics Market, By Country
3.4. Other Diagnostics
3.4.1 Other Diagnostics Market, By Region
3.4.1.1 North America Other Diagnostics Market, By Country
3.4.1.2 Europe Other Diagnostics Market, By Country
3.4.1.3 Asia-Pacific Other Diagnostics Market, By Country
3.4.1.4 Rest of World Other Diagnostics Market, By Country
4. Global Oncology NGS Market, By End-use
4.1. Overview
4.2. Hospitals
4.2.1 Hospitals Market, By Region
4.2.1.1 North America Hospitals Market, By Country
4.2.1.2 Europe Hospitals Market, By Country
4.2.1.3 Asia-Pacific Hospitals Market, By Country
4.2.1.4 Rest of World Hospitals Market, By Country
4.3. Clinics
4.3.1 Clinics Market, By Region
4.3.1.1 North America Clinics Market, By Country
4.3.1.2 Europe Clinics Market, By Country
4.3.1.3 Asia-Pacific Clinics Market, By Country
4.3.1.4 Rest of World Clinics Market, By Country
4.4. Laboratories
4.4.1 Laboratories Market, By Region
4.4.1.1 North America Laboratories Market, By Country
4.4.1.2 Europe Laboratories Market, By Country
4.4.1.3 Asia-Pacific Laboratories Market, By Country
4.4.1.4 Rest of World Laboratories Market, By Country
5. Global Oncology NGS Market, By Region
5.1. Overview
5.2. North America
5.2.1 North America Oncology NGS Market, By Technology
5.2.2 North America Oncology NGS Market, By Workflow
5.2.3 North America Oncology NGS Market, By Application
5.2.4 North America Oncology NGS Market, By End-use
5.2.5 North America Oncology NGS Market, By Country
5.2.5.1 U.S.
5.2.5.1.1 U.S. Oncology NGS Market, By Technology
5.2.5.1.2 U.S. Oncology NGS Market, By Workflow
5.2.5.1.3 U.S. Oncology NGS Market, By Application
5.2.5.1.4 U.S. Oncology NGS Market, By End-use
5.2.5.2 Canada
5.2.5.2.1 Canada Oncology NGS Market, By Technology
5.2.5.2.2 Canada Oncology NGS Market, By Workflow
5.2.5.2.3 Canada Oncology NGS Market, By Application
5.2.5.2.4 Canada Oncology NGS Market, By End-use
5.3. Europe
5.3.1 Europe Oncology NGS Market, By Technology
5.3.2 Europe Oncology NGS Market, By Workflow
5.3.3 Europe Oncology NGS Market, By Application
5.3.4 Europe Oncology NGS Market, By End-use
5.3.5 Europe Oncology NGS Market, By Country
5.3.5.1 Germany
5.3.5.1.1 Germany Oncology NGS Market, By Technology
5.3.5.1.2 Germany Oncology NGS Market, By Workflow
5.3.5.1.3 Germany Oncology NGS Market, By Application
5.3.5.1.4 Germany Oncology NGS Market, By End-use
5.3.5.2 U.K.
5.3.5.2.1 U.K. Oncology NGS Market, By Technology
5.3.5.2.2 U.K. Oncology NGS Market, By Workflow
5.3.5.2.3 U.K. Oncology NGS Market, By Application
5.3.5.2.4 U.K. Oncology NGS Market, By End-use
5.3.5.3 France
5.3.5.3.1 France Oncology NGS Market, By Technology
5.3.5.3.2 France Oncology NGS Market, By Workflow
5.3.5.3.3 France Oncology NGS Market, By Application
5.3.5.3.4 France Oncology NGS Market, By End-use
5.3.5.4 Italy
5.3.5.4.1 Italy Oncology NGS Market, By Technology
5.3.5.4.2 Italy Oncology NGS Market, By Workflow
5.3.5.4.3 Italy Oncology NGS Market, By Application
5.3.5.4.4 Italy Oncology NGS Market, By End-use
5.3.5.5 Spain
5.3.5.5.1 Spain Oncology NGS Market, By Technology
5.3.5.5.2 Spain Oncology NGS Market, By Workflow
5.3.5.5.3 Spain Oncology NGS Market, By Application
5.3.5.5.4 Spain Oncology NGS Market, By End-use
5.3.5.6 Rest of Europe
5.3.5.6.1 Rest of Europe Oncology NGS Market, By Technology
5.3.5.6.2 Rest of Europe Oncology NGS Market, By Workflow
5.3.5.6.3 Rest of Europe Oncology NGS Market, By Application
5.3.5.6.4 Rest of Europe Oncology NGS Market, By End-use
5.4. Asia-Pacific
5.4.1 Asia-Pacific Oncology NGS Market, By Technology
5.4.2 Asia-Pacific Oncology NGS Market, By Workflow
5.4.3 Asia-Pacific Oncology NGS Market, By Application
5.4.4 Asia-Pacific Oncology NGS Market, By End-use
5.4.5 Asia-Pacific Oncology NGS Market, By Country
5.4.5.1 China
5.4.5.1.1 China Oncology NGS Market, By Technology
5.4.5.1.2 China Oncology NGS Market, By Workflow
5.4.5.1.3 China Oncology NGS Market, By Application
5.4.5.1.4 China Oncology NGS Market, By End-use
5.4.5.2 Japan
5.4.5.2.1 Japan Oncology NGS Market, By Technology
5.4.5.2.2 Japan Oncology NGS Market, By Workflow
5.4.5.2.3 Japan Oncology NGS Market, By Application
5.4.5.2.4 Japan Oncology NGS Market, By End-use
5.4.5.3 South Korea
5.4.5.3.1 South Korea Oncology NGS Market, By Technology
5.4.5.3.2 South Korea Oncology NGS Market, By Workflow
5.4.5.3.3 South Korea Oncology NGS Market, By Application
5.4.5.3.4 South Korea Oncology NGS Market, By End-use
5.4.5.4 India
5.4.5.4.1 India Oncology NGS Market, By Technology
5.4.5.4.2 India Oncology NGS Market, By Workflow
5.4.5.4.3 India Oncology NGS Market, By Application
5.4.5.4.4 India Oncology NGS Market, By End-use
5.4.5.5 Singapore
5.4.5.5.1 Singapore Oncology NGS Market, By Technology
5.4.5.5.2 Singapore Oncology NGS Market, By Workflow
5.4.5.5.3 Singapore Oncology NGS Market, By Application
5.4.5.5.4 Singapore Oncology NGS Market, By End-use
5.4.5.6 Rest of Asia
5.4.5.6.1 Rest of Asia Oncology NGS Market, By Technology
5.4.5.6.2 Rest of Asia Oncology NGS Market, By Workflow
5.4.5.6.3 Rest of Asia Oncology NGS Market, By Application
5.4.5.6.4 Rest of Asia Oncology NGS Market, By End-use
5.5. Rest of World
5.5.1 Rest of World Oncology NGS Market, By Technology
5.5.2 Rest of World Oncology NGS Market, By Workflow
5.5.3 Rest of World Oncology NGS Market, By Application
5.5.4 Rest of World Oncology NGS Market, By End-use
5.5.5 Rest of World Oncology NGS Market, By Country
5.5.5.1 Brazil
5.5.5.1.1 Brazil Oncology NGS Market, By Technology
5.5.5.1.2 Brazil Oncology NGS Market, By Workflow
5.5.5.1.3 Brazil Oncology NGS Market, By Application
5.5.5.1.4 Brazil Oncology NGS Market, By End-use
5.5.5.2 Mexico
5.5.5.2.1 Mexico Oncology NGS Market, By Technology
5.5.5.2.2 Mexico Oncology NGS Market, By Workflow
5.5.5.2.3 Mexico Oncology NGS Market, By Application
5.5.5.2.4 Mexico Oncology NGS Market, By End-use
5.5.5.3 South Africa
5.5.5.3.1 South Africa Oncology NGS Market, By Technology
5.5.5.3.2 South Africa Oncology NGS Market, By Workflow
5.5.5.3.3 South Africa Oncology NGS Market, By Application
5.5.5.3.4 South Africa Oncology NGS Market, By End-use
5.5.5.4 Australia
5.5.5.4.1 Australia Oncology NGS Market, By Technology
5.5.5.4.2 Australia Oncology NGS Market, By Workflow
5.5.5.4.3 Australia Oncology NGS Market, By Application
5.5.5.4.4 Australia Oncology NGS Market, By End-use
5.5.5.5 ROW Countries
5.5.5.5.1 ROW Countries Oncology NGS Market, By Technology
5.5.5.5.2 ROW Countries Oncology NGS Market, By Workflow
5.5.5.5.3 ROW Countries Oncology NGS Market, By Application
5.5.5.5.4 ROW Countries Oncology NGS Market, By End-use
ROW Countries Oncology NGS Market Value, By End-use, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 2. Whole Genome Sequencing Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Whole Genome Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Whole Genome Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Whole Genome Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Whole Genome Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 7. Whole Exome Sequencing Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Whole Exome Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Whole Exome Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Whole Exome Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Whole Exome Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 12. Targeted Sequencing & Resequencing Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Targeted Sequencing & Resequencing Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Targeted Sequencing & Resequencing Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Targeted Sequencing & Resequencing Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Targeted Sequencing & Resequencing Market Value, By Country, 2022-2031, Million USD
TABLE 17. Global Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 18. NGS Pre-Sequencing Market Value, By Region, 2022-2031, Million USD
TABLE 19. North America NGS Pre-Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 20. Europe NGS Pre-Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 21. Asia-Pacific NGS Pre-Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 22. Rest of World NGS Pre-Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 23. NGS Sequencing Market Value, By Region, 2022-2031, Million USD
TABLE 24. North America NGS Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 25. Europe NGS Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 26. Asia-Pacific NGS Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 27. Rest of World NGS Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 28. NGS Data Analysis Market Value, By Region, 2022-2031, Million USD
TABLE 29. North America NGS Data Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 30. Europe NGS Data Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 31. Asia-Pacific NGS Data Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 32. Rest of World NGS Data Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 33. Global Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 34. Screening Market Value, By Region, 2022-2031, Million USD
TABLE 35. North America Screening Market Value, By Country, 2022-2031, Million USD
TABLE 36. Europe Screening Market Value, By Country, 2022-2031, Million USD
TABLE 37. Asia-Pacific Screening Market Value, By Country, 2022-2031, Million USD
TABLE 38. Rest of World Screening Market Value, By Country, 2022-2031, Million USD
TABLE 39. Companion Diagnostics Market Value, By Region, 2022-2031, Million USD
TABLE 40. North America Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 41. Europe Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 42. Asia-Pacific Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 43. Rest of World Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 44. Other Diagnostics Market Value, By Region, 2022-2031, Million USD
TABLE 45. North America Other Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 46. Europe Other Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 47. Asia-Pacific Other Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 48. Rest of World Other Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 49. Global Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 50. Hospitals Market Value, By Region, 2022-2031, Million USD
TABLE 51. North America Hospitals Market Value, By Country, 2022-2031, Million USD
TABLE 52. Europe Hospitals Market Value, By Country, 2022-2031, Million USD
TABLE 53. Asia-Pacific Hospitals Market Value, By Country, 2022-2031, Million USD
TABLE 54. Rest of World Hospitals Market Value, By Country, 2022-2031, Million USD
TABLE 55. Clinics Market Value, By Region, 2022-2031, Million USD
TABLE 56. North America Clinics Market Value, By Country, 2022-2031, Million USD
TABLE 57. Europe Clinics Market Value, By Country, 2022-2031, Million USD
TABLE 58. Asia-Pacific Clinics Market Value, By Country, 2022-2031, Million USD
TABLE 59. Rest of World Clinics Market Value, By Country, 2022-2031, Million USD
TABLE 60. Laboratories Market Value, By Region, 2022-2031, Million USD
TABLE 61. North America Laboratories Market Value, By Country, 2022-2031, Million USD
TABLE 62. Europe Laboratories Market Value, By Country, 2022-2031, Million USD
TABLE 63. Asia-Pacific Laboratories Market Value, By Country, 2022-2031, Million USD
TABLE 64. Rest of World Laboratories Market Value, By Country, 2022-2031, Million USD
TABLE 65. Global Oncology NGS Market Value, By Region, 2022-2031, Million USD
TABLE 66. North America Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 67. North America Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 68. North America Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 69. North America Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 70. North America Oncology NGS Market Value, By Country, 2022-2031, Million USD
TABLE 71. U.S. Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 72. U.S. Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 73. U.S. Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 74. U.S. Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 75. Canada Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 76. Canada Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 77. Canada Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 78. Canada Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 79. Europe Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 80. Europe Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 81. Europe Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 82. Europe Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 83. Europe Oncology NGS Market Value, By Country, 2022-2031, Million USD
TABLE 84. Germany Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 85. Germany Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 86. Germany Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 87. Germany Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 88. U.K. Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 89. U.K. Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 90. U.K. Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 91. U.K. Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 92. France Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 93. France Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 94. France Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 95. France Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 96. Italy Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 97. Italy Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 98. Italy Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 99. Italy Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 100. Spain Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 101. Spain Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 102. Spain Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 103. Spain Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 104. Rest of Europe Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 105. Rest of Europe Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 106. Rest of Europe Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 107. Rest of Europe Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 108. Asia-Pacific Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 109. Asia-Pacific Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 110. Asia-Pacific Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 111. Asia-Pacific Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 112. Asia-Pacific Oncology NGS Market Value, By Country, 2022-2031, Million USD
TABLE 113. China Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 114. China Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 115. China Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 116. China Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 117. Japan Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 118. Japan Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 119. Japan Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 120. Japan Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 121. South Korea Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 122. South Korea Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 123. South Korea Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 124. South Korea Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 125. India Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 126. India Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 127. India Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 128. India Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 129. Singapore Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 130. Singapore Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 131. Singapore Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 132. Singapore Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 133. Rest of Asia Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 134. Rest of Asia Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 135. Rest of Asia Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 136. Rest of Asia Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 137. Rest of World Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 138. Rest of World Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 139. Rest of World Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 140. Rest of World Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 141. Rest of World Oncology NGS Market Value, By Country, 2022-2031, Million USD
TABLE 142. Brazil Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 143. Brazil Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 144. Brazil Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 145. Brazil Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 146. Mexico Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 147. Mexico Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 148. Mexico Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 149. Mexico Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 150. South Africa Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 151. South Africa Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 152. South Africa Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 153. South Africa Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 154. Australia Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 155. Australia Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 156. Australia Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 157. Australia Oncology NGS Market Value, By End-use, 2022-2031, Million USD
TABLE 158. ROW Countries Oncology NGS Market Value, By Technology, 2022-2031, Million USD
TABLE 159. ROW Countries Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
TABLE 160. ROW Countries Oncology NGS Market Value, By Application, 2022-2031, Million USD
TABLE 161. ROW Countries Oncology NGS Market Value, By End-use, 2022-2031, Million USD
ROW Countries Oncology NGS Market Value, By End-use, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us